Search

everythinglearnresearchcommunity

for

Search:↓

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Fructus Psoraleae may help treat hair loss by inhibiting 5-α reductase and affecting the Nrf2-Keap1 pathway.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The frizzy mouse and hairless rat mutations are due to changes in the Prss8 gene.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Esrp1 is important for skin health by helping form and maintain the skin barrier.

Lack of KSR1 stops certain skin tumors in mice.

MC-1R is present in skin cells and may help reduce inflammation.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

BMS-470539 reduces skin fibrosis and inflammation.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

S1PR1 helps control inflammation in blood vessel cells by affecting gene activity differently in various cell types and locations.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.